The primary efficacy outcome occurred in @ ( @ % ) of @ patients in the bivalirudin group and @ ( @ % ) of @ patients in the heparin group ( absolute risk difference @ % ; relative risk -LSB- RR -RSB- @ , @ % CI @-@ , p = @ ) .